Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Exelixis, Inc. (EXEL) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (214)	1/6/2006 3:09:02 PM
From: rkrw	Read Replies (2) \| Respond to of 930

I was the sucker born last minute. Just ask the contractor I had to fire last Spring. I figured there was about a 100% chance exel would get back to 10. Didn't know when. With so many compounds hitting targets of great interest there was no sense in burying exel. 2001/2002 downturn scared the crap out of a lot of bios. Big aspirations take big money and maybe you sacrifice some short term upside for stability and long term value. exel certainly has a lot more drugs in the hopper thanks to gsk. I'm very curious to see what exel looks like a year or two after gsk concludes their exel deal with their 2-3 drug picks.